Physician profile
Andrew Horowitz
NPI 1336337591
$8,024.27
in general payments reported to CMS, 2019-2025
19 companies · $2,417 in 2025
The $2,417 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,528 · 2020: $40.90 · 2021: $486 · 2022: $475 · 2023: $2,368 · 2024: $709 · 2025: $2,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,114 · Travel and Lodging: $2,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,114.03 |
| Travel and Lodging | $2,379.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,907.75 | 2021-2025 | Interstim, Nuro |
| Procept Biorobotics Corporation | $1,895.40 | 2024-2025 | Aquabeam System |
| Neotract INC. | $886.32 | 2019-2020 | |
| Medtronic USA, INC. | $472.13 | 2019-2020 | |
| Boston Scientific Corporation | $202.33 | 2021-2025 | Vercise |
| Olympus America INC. | $160.69 | 2019-2024 | Olympus, Soltive, Bovie |
| Astellas Pharma US INC | $107.58 | 2019-2021 | |
| Lumenis, INC | $63.10 | 2021 | |
| Coopersurgical, INC. | $60.85 | 2021-2025 | Paragard T 380a |
| Myovant Sciences INC. | $43.80 | 2022 | |
| Urovant Sciences INC | $35.21 | 2022 | |
| Endo Pharmaceuticals INC. | $33.96 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.57 | 2019 | |
| Axonics, INC. | $29.80 | 2022 | |
| Teleflex LLC | $24.52 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $19.50 | 2024 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $18.93 | 2021 | |
| Therapeuticsmd, INC. | $16.19 | 2019 | |
| Janssen Biotech, INC. | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.